Aspirin for Primary Prevention — Time to Rethink Our Approach [making the case for a precision medicine approach using platelet phenotype]
Only 10% of companies are are truly resilient against supply chain disruptions – an alarming 80% are not
Looking Ahead: The Future of Cell Therapy in Oncology Health Transformation Institute (HTI) the most comprehensive knowledge portal on health transformation Joaquim Cardoso MSc*Founder, CEO and CSO.November Read More » 24 de novembro de 2022